www.fdanews.com/articles/86031-new-zealand-extends-meningococcal-immunization-campaign
NEW ZEALAND EXTENDS MENINGOCOCCAL IMMUNIZATION CAMPAIGN
April 13, 2006
New Zealand's meningococcal B immunization program, which uses Chiron's MeNZBT
vaccine, has been extended following successful results. Speaking at a celebration
to mark the delivery of the three millionth vaccine dose, New Zealand minister
of health Pete Hodgson said that new data confirms that the end of the meningococcal
B epidemic is in sight.
Pharmaceutical
Business Review